<DOC>
	<DOCNO>NCT03067597</DOCNO>
	<brief_summary>To demonstrate efficacy controlled-release dinoprostone vaginal insert ( DVI ) cervical ripen success ( either Bishop Score ( BS ) ≥7 vaginal delivery ) within 12 hour vaginal insert administration .</brief_summary>
	<brief_title>An Open-label Trial Investigating Efficacy Safety Vaginal Insert Pregnant Women Term</brief_title>
	<detailed_description />
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Pregnant woman term ( ≥37 week 0 day &lt; 41 week 0 day gestation ) Baseline visit Candidate pharmacologic induction labour Singleton pregnancy live infant vertex presentation Baseline BS ≤ 4 Baseline visit Parity ≤ 3 ( parity define one birth live stillbirth 22 week 0 day gestation ) Written informed consent Women active labour Presence uterine cervical scar include scar previous caesarean section , previous cone biopsy cervix loop electrosurgical excision procedure ( LEEP ) Uterine abnormality e.g . bicornuate uterus Administration oxytocin , cervical ripen labour inducing agent ( include mechanical method ) tocolytic drug within 7 day prior IMP administration . Magnesium sulfate permit prescribed treatment preeclampsia pregnancy induce hypertension Presence follow conditions/symptoms : Systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 110 mmHg . Platelets &lt; 100,000/µL . Increased liver function test ( 2x upper limit normal range ) . Severe , persistent right upper quadrant/epigastric pain . Progressive renal insufficiency : Creatinine &gt; 1.1 mg/dL , Doubling creatinine absence renal disease . Pulmonary edema . New onset cerebral visual disturbance . Suspected confirm cephalopelvic disproportion and/or fetal malpresentation Diagnosed congenital abnormality , include polydactyly Suspected confirm intrauterine growth retardation ( ≤ mean 1.5 SD normal estimate fetal weight date ) Any evidence fetal compromise Baseline visit ( e.g. , nonreassuring fetal heart rate pattern , meconium staining , history nonreassuring fetal status abnormal umbilical artery Doppler wave form ) Intake medication aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) V2 Ruptured membrane ≥ 48 hour prior IMP administration Suspected clinical chorioamnionitis Current pelvic inflammatory disease , unless adequate prior treatment institute Fever ( axillary temperature ≥ 38.0°C ) Baseline visit Any condition vaginal delivery contraindicate ( e.g. , placenta previa unexplained vaginal bleeding time 24 week 0 day pregnancy ) Known suspect allergy , dinoprostone , prostaglandins constituent IMP Any condition urgently require delivery History asthma glaucoma Unable comply protocol Any medical condition judgement investigator would impair participation trial</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>